Sunao Fujioka is the founder of bitBiome. bitBiome has raised $22M in total funding. Latest round: Seed.
Sunao Fujioka is the Representative Director and CEO of AlphaFusion Inc., a startup focused on the societal implementation of astatine (At-211)-based drug discovery, aiming to advance targeted alpha therapy for cancer treatment. Prior to this role, he held management positions at bitBiome, where he led commercialization and fundraising efforts for its single-cell genome analysis technology specializing in microbes. His career also includes experience at McKinsey, Janssen Pharma, and MSD, where he played a key role in the launch of Keytruda.
Full founder directory · Investor directory · Company funding database · Fundraising library